Thermo Fisher sells its microbiology business to Astorg

 

Press release from Thermo Fisher (and the once great Oxoid brand): 

 

Thermo Fisher Scientific recently announced it has entered into an agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm with deep expertise in healthcare, focused on a select set of subsectors, including pharmaceutical services and technology, medtech and related services, life science tools, and diagnostics. 

 

Read about Oxoid's hisotry here: History and development of microbiological culture media 

 

For 100 years, we have been dedicated to serving microbiologists. From antibiotic resistance monitoring, to safeguarding the integrity of the global food supply chain, our tools have aided microbiology leaders in their essential work since 1924, and we expect that to continue as part of Astorg. We are confident that with Astorg as owners, the microbiology business will benefit from its industry expertise in healthcare creating an environment where it can thrive and further unlock its full potential. 

This decision follows a thoughtful evaluation as part of Thermo Fisher’s ongoing business strategy to actively manage and strengthen our portfolio. The microbiology business has built strong capabilities, talented teams and a solid operational foundation. We believe that under Astorg’s ownership, with focused investment and strategic attention, it will be well positioned to further accelerate growth and continue delivering high value to customers.  

We expect the transaction will be completed in the second half of 2026, subject to customary closing conditions and applicable regulatory approvals. Until the transaction is complete, Thermo Fisher will continue to operate the microbiology business. 

 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

When Should You Consider a Sober Companion for Yourself or a Loved One?

 

Recovery is not just about stopping substance use—it’s about learning how to live again. While treatment programs provide a strong foundation, the real challenge often begins after leaving rehab.

Many individuals and families ask the same question:
“How do we make sure recovery continues at home?”

This is where a sober companion can make a meaningful difference. But how do you know when it’s the right time to consider one?

In this article, we’ll walk through the key situations where a sober companion can provide essential support—and help protect long-term recovery.

 

Understanding the Risk in Early Recovery

Recovery is a process, not a single event. The early stages can feel uncertain, emotional, and sometimes overwhelming.

According to the National Institute on Drug Abuse (NIDA), relapse rates for substance use disorders range from 40% to 60%, especially in the first year after treatment.

This doesn’t mean recovery is failing—it simply shows that ongoing support is critical.

A sober companion helps bridge the gap between structured care and real-life challenges.

 

What Is a Sober Companion?

A sober companion, also known as a recovery companion, is a trained professional who provides one-on-one support during recovery.

They are present in real-life situations—at home, during travel, or at events—helping individuals stay safe, focused, and supported.

Their role is not just to monitor behavior, but to:

●     Offer guidance during difficult moments

●     Help manage triggers and stress

●     Provide accountability and encouragement

●     Support healthy routines and decisions

 

When Should You Consider a Sober Companion?

There is no single “right time,” but there are clear situations where a sober companion can be especially helpful.

 

1. After Leaving Inpatient Treatment

The transition from rehab to home is one of the most vulnerable periods in recovery.

In treatment, there is structure, routine, and constant support. At home, those safeguards are no longer in place.

A sober companion can help:

●     Create a structured daily routine

●     Reduce exposure to triggers

●     Provide emotional support during adjustment

This support can ease the transition and reduce the risk of relapse.

 

2. If There Is a History of Relapse

Relapse is common, but repeated relapse may signal the need for additional support.

If you or a loved one have struggled to maintain sobriety after treatment, a sober companion can help by:

●     Identifying patterns that lead to relapse

●     Providing real-time intervention during high-risk moments

●     Offering consistent accountability

This proactive approach can break the cycle and create a stronger recovery foundation.

 

3. During High-Stress Life Events

Life doesn’t pause for recovery. Stressful situations can quickly increase the risk of relapse.

These may include:

●     Career changes or job pressure

●     Relationship conflicts

●     Financial stress

●     Major life transitions

A sober companion provides steady support during these moments, helping individuals:

●     Manage stress in healthy ways

●     Stay grounded and focused

●     Avoid impulsive decisions

 

4. Before Entering Treatment

Many people don’t realize that support can begin before treatment starts.

The period leading up to rehab can be unstable. Individuals may feel anxious, resistant, or overwhelmed.

A sober companion can:

●     Provide encouragement and reassurance

●     Help maintain safety before admission

●     Ensure a smooth transition into treatment

This early support can make entering treatment less stressful and more successful.

 

5. During Travel or High-Risk Situations

Travel and social events can introduce unexpected triggers.

Situations like:

●     Weddings or parties

●     Business trips

●     Vacations

●     Family gatherings

can feel overwhelming, especially in early recovery.

A sober companion can:

●     Travel alongside the individual

●     Help navigate challenging environments

●     Provide immediate support if triggers arise

This allows individuals to participate in life without compromising their recovery.

 

6. If There Is Limited Support at Home

A strong support system is one of the most important factors in recovery.

However, not everyone has access to:

●     Understanding family members

●     A stable home environment

●     A supportive peer network

According to SAMHSA (Substance Abuse and Mental Health Services Administration), social support plays a major role in long-term recovery success.

A sober companion can help fill this gap by offering:

●     Consistent presence and encouragement

●     Guidance in building healthy relationships

●     Support in creating a recovery-focused environment

 

7. When Managing Co-Occurring Mental Health Conditions

Many individuals in recovery also face mental health challenges such as anxiety, depression, or trauma.

SAMHSA reports that nearly 50% of people with a substance use disorder also have a co-occurring mental health condition.

Managing both can feel overwhelming.

A sober companion can help by:

●     Encouraging adherence to treatment plans

●     Supporting emotional regulation

●     Providing stability during difficult moments

This integrated support can improve overall well-being and recovery outcomes.

 

8. When Accountability Is Needed

Recovery requires consistency. Without accountability, it can be easy to fall back into old habits.

A sober companion helps by:

●     Keeping individuals accountable to their goals

●     Reinforcing healthy routines

●     Providing gentle, supportive guidance

This accountability is not about control—it’s about supporting progress.

 

9. During the Early Stages of Recovery

The first few weeks and months of recovery are often the most fragile.

Cravings, emotional ups and downs, and uncertainty are common.

A sober companion provides:

●     Daily support and structure

●     Immediate help during cravings

●     Encouragement during difficult moments

This consistent presence can make early recovery feel more manageable.

 

10. When Building a New Lifestyle

Recovery is not just about avoiding substances—it’s about creating a new way of living.

This includes:

●     Developing healthy habits

●     Rebuilding relationships

●     Finding purpose and balance

A sober companion helps guide this process by:

●     Encouraging positive routines

●     Supporting personal growth

●     Helping individuals stay focused on long-term goals

Over time, this leads to greater independence and confidence.

 

It’s More Than Support—It’s a Partnership

Working with a sober companion is not about dependence. It’s about building strength, stability, and confidence.

It’s a partnership rooted in:

●     Compassion

●     Trust

●     Accountability

●     Respect

Each step forward—no matter how small—moves recovery in the right direction.

 

Final Thoughts

Knowing when to seek additional support can make all the difference in recovery.

A sober companion can be especially helpful during:

●     Transitions after treatment

●     High-stress or high-risk situations

●     Periods of uncertainty or vulnerability

●     Times when extra guidance and accountability are needed

Recovery is a journey, and no one has to walk it alone.

With the right support, individuals can move beyond survival—and begin to build a life that feels stable, meaningful, and truly their own.

 

Sources

1. National Institute on Drug Abuse (NIDA) – Relapse Rates
   https://nida.nih.gov/publications/research-reports/relapse-rates-addiction
2. National Institute on Drug Abuse (NIDA) – Treatment and Recovery
   https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
3. Substance Abuse and Mental Health Services Administration (SAMHSA)
   https://www.samhsa.gov/find-help/recovery
4. SAMHSA – Co-Occurring Disorders
   https://www.samhsa.gov/mental-health/co-occurring-disorders

 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

What Happens When Innovation Outpaces Talent Development in Microbiology?

 

                                                                        Microbiologist by Tim Sandle

The life sciences skills gap continues to widen as breakthroughs in microbiology accelerate at an unprecedented pace. Advances in synthetic biology and antimicrobial resistance research influence what is possible in research and commercialization. However, while innovation surges forward, talent pipelines struggle to keep pace.

This lag leaves organizations searching for professionals who can bridge deep scientific expertise with technical and operational demands. The growing disconnect places pressure on research and development timelines and on large-scale production readiness. It also signals a critical need for more agile workforce strategies that can grow alongside scientific progress.

The Acceleration of Innovation in Life Sciences

Artificial intelligence (AI)-driven drug discovery and microbiome therapeutics drive rapid transformation across microbiology and pharmaceutical life sciences. AI tools now support the optimization of clinical trials and enable faster identification of novel therapeutic targets, which improves efficiency and precision in development pipelines. 

These advancements demand interdisciplinary expertise that blends biology and engineering. They create a new standard for scientific and technical fluency. Innovation cycles now move far faster than traditional education and training models, challenging talent development systems to keep pace with industry needs.

The Skills Gap in Pharmaceutical Fields

The hybrid skills gap refers to the shortage of professionals who combine deep scientific expertise with applied technical and digital capabilities. Industry sentiment reflects growing concern, with 75% of leaders expecting these shortages to worsen as innovation accelerates. Critical gaps continue to emerge in areas such as bioinformatics and advanced automation systems, where demand consistently outpaces supply.

Many experienced professionals bring strong domain knowledge but lack cross-domain fluency in data-driven and automated environments. Meanwhile, newer talent often enters the workforce without sufficient hands-on lab or industry exposure. This imbalance creates friction across research, development and production workflows, which limits the ability to capitalize on emerging technologies.

Root Causes Behind the Life Sciences Skills Gap

Misalignment between academic curricula and industry needs remains a core driver of the life sciences skills gap, particularly as emerging technologies affect required competencies. Training programs often adapt slowly compared to fast-moving research and development environments, which leaves graduates unprepared for real-world applications.

Traditional classroom-based instruction is still prevalent, especially in building in-depth theoretical understanding and delivering structured curricula that support foundational knowledge.

However, competition for talent across biotech, pharma and adjacent industries intensifies hiring challenges and limits available expertise. Additionally, limited access to continuous professional development within organizations prevents existing teams from improving alongside new scientific and technological demands.

Consequences of Letting Innovation Outpace Talent Development

A slower translation of research into clinical and commercial applications is a clear consequence when talent gaps persist. Operational risks increase in highly regulated environments, such as biomanufacturing and quality control, where precision and compliance are critical. Bottlenecks often emerge when scaling complex processes, limiting the ability to meet demand.

Organizations may turn to outsourcing to fill capability gaps, which can reduce internal expertise and long-term control over innovation. These pressures pose a real risk of innovation stagnation, even when strong scientific pipelines exist. This environment can also delay responses to emerging health threats and reduce competitiveness in global markets.

The Real-World Impact on Microbiology and Pharmaceutical Operations

Delays in antimicrobial development and slower responses to emerging pathogens become more likely when critical skills gaps persist. Maintaining compliance and consistent quality standards grows increasingly difficult within complex, highly regulated production systems. Lab workflows often lose efficiency when automation and digital tools remain underutilized due to limited expertise.

High development costs for AI algorithms and personalized therapies place additional strain on budgets, particularly for smaller biotech firms. These pressures accumulate across teams, which leads to burnout and a noticeable decline in overall innovation capacity. As a result, organizations may struggle to meet regulatory timelines and market expectations.

Strategies to Close the Skills Gap in Life Sciences

Addressing the life sciences skills gap requires stronger collaboration between universities and industry to align curricula with real-world demands and emerging technologies. Organizations must also prioritize upskilling and reskilling initiatives to help existing employees adapt to new tools and interdisciplinary workflows. Hiring strategies should shift toward adaptability and cross-functional learning.

Companies must value professionals who can operate across scientific and technical domains rather than narrow specialization alone. Danaher demonstrates this approach by offering roles to seasoned experts and early-career talent, thereby advancing critical areas such as cell and gene therapies. Life sciences companies can also leverage automation and digital lab platforms to augment human capabilities and accelerate knowledge transfer across teams.

The Role of Leadership in Driving Talent Transformation

Leadership accountability is central to elevating talent development as a strategic function rather than a reactive initiative. Many leaders aim to deliver on the promise of emerging scientific knowledge but struggle with internal misalignment, including reactive resourcing and unclear long-term talent needs.

Aligning workforce planning with long-term innovation goals helps organizations build the capabilities required to support sustained growth and scientific advancement. A culture that prioritizes continuous learning and cross-disciplinary collaboration enables teams to adapt more effectively to rapid change. This approach strengthens organizational resilience and the ability to translate innovation into real-world impact.

Turning the Life Sciences Skills Gap Into a Strategic Advantage

The gap between innovation and talent development presents a significant risk and a powerful opportunity for the industry. Addressing the life sciences skills gap remains essential to sustaining progress across microbiology and pharmaceutical innovation. Organizations and professionals must take an active role in building a future-ready workforce that can keep pace with scientific advancement.

Author Bio

Jackson Toone

Digital Media Specialist

(On Behalf of Danaher)

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)